Choline Fenofibrate

CAT: 0804-HY-14739-01Size: 5 mgDry Ice: NoHazardous: No
CAT#:0804-HY-14739-01Size:5 mg
Selected
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
Choline Fenofibrate (ABT-335), a choline salt of Fenofibric acid (HY-B0760), releases free Fenofibric acid in the gastrointestinal tract. Fenofibric acid is a PPAR activator with antihyperlipidemic effect[1].
CAS Number
[856676-23-8]
Product Name Alternative
ABT-335
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
COX; PPAR
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Immunology/Inflammation; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor
Applications
COVID-19-anti-virus
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/Choline-Fenofibrate.html
Purity
99.86
Solubility
DMSO : 20 mg/mL (ultrasonic) |Ethanol : 33.33 mg/mL (ultrasonic) |H2O : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=CC=C(OC(C)(C([O-])=O)C)C=C1)C2=CC=C(Cl)C=C2.C[N+](C)(CCO)C
Molecular Formula
C22H28ClNO5
Molecular Weight
421.91
Precautions
H302, H315, H319, H335
References & Citations
[1]Xudan Wei, et al. Absolute oral bioavailability of fenofibric acid and choline fenofibrate in rats determined by ultra-performance liquid chromatography tandem mass spectrometry. Biomed Chromatogr. 2017 Apr;31 (4) .
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
Launched

Popular Products